Editorial
Accepted on 09 May 2024
Editorial: Anti-inflammatory drug development focusing on immune mediated diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413141
Type at least 3 characters
1,584 articles
Articles
Original Research
Accepted on 07 May 2024
Mechanism of isorhynchophylline in lipopolysaccharide-induced acute lung injury based on proteomic technology
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1397498
Review
Accepted on 06 May 2024
Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407336
Review
Accepted on 06 May 2024
The Role of Inflammation in Central Serous Chorioretinopathy: From Mechanisms to Therapeutic Prospects
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1200492
Original Research
Accepted on 02 May 2024
Melatonin Modulates Neuroinflammatory Response and Microglial Activation in Mice Exposed to Dim Blue Light at Night
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1416350
Original Research
Accepted on 30 Apr 2024
Hedgehog signaling is a promising target for the treatment of hepatic fibrogenesis: A new management strategy using itraconazole-loaded nanoparticles
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377980
Original Research
Accepted on 29 Apr 2024
Establishment of a human nasal epithelium model of histamineinduced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1393702
Review
Accepted on 29 Apr 2024
Emerging Biologic Frontiers for Sjogren's Syndrome: Unveiling Novel Approaches with Emphasis on Extra Glandular Pathology
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377055
Original Research
Published on 29 Apr 2024
Bergamottin (Ber) ameliorates the progression of osteoarthritis via the Sirt1/NF-κB pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389786
- 173 views
Review
Accepted on 26 Apr 2024
Potential use of antioxidants for the treatment of chronic inflammatory diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1378335
- 222 views
Original Research
Accepted on 26 Apr 2024
Sitagliptin ameliorates L-arginine-induced acute pancreatitis via modulating inflammatory cytokines expression and combating oxidative stress
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389670
Review
Published on 24 Apr 2024
Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1387585
- 225 views
Review
Accepted on 22 Apr 2024
Inflammation and cancer: Friend or foe?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1385479
- 137 views
Original Research
Accepted on 22 Apr 2024
Lobetyolin protects mice against LPS-induced sepsis by downregulating the production of inflammatory cytokines in macrophage
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1405163
Review
Accepted on 17 Apr 2024
Recommendations for nutritional supplements for dry eye disease: current advances
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1388787
Review
Published on 10 Apr 2024
Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377113
- 536 views